top of page
The Human Variable
Search


Recalibrating the Demographic Landscape of ME/CFS in the United States
Using CYNAERA’s US-CCUC™ model, we present a corrected demographic landscape grounded in published science, epidemiological data, and terrain-calibrated prevalence modeling. For the first time, undocumented immigrant populations and ancestral dietary biology are incorporated as visible drivers of disease prevalence. Our analysis demonstrates that half of Americans with ME/CFS are non-white, and that prevalence in certain groups is likely higher when adjusted for baseline into
Aug 25


The Pediatric ME/CFS Crisis: Undercounting, Post-COVID Onset, and Diagnostic Gaps
Using CYNAERA’s US-CCUC™ (U.S. Chronic Condition Undercount Correction – Pediatric Edition) methodology, we estimate 1.5–3 million U.S. children and adolescents and 10–20 million globally meet ME/CFS criteria in 2025.
Aug 25


State-Level ME/CFS Prevalence Methodology
Using CYNAERA’s recalibrated tiered prevalence model, weighted for environmental exposure, access to paid sick leave, and diagnostic inequity, we estimate that around 14.4 million Americans currently meet the diagnostic criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Aug 25


ME/CFS Prevalence Formula US-CCUC™-Aligned
CYNAERA’s US-CCUC™ (Chronic Condition Undercount Correction – U.S.) model provides a corrected formula for estimating the real burden of ME/CFS. It builds on pre-pandemic cases, integrates the Long COVID surge, and corrects for the 80–90% of patients who were always there — but never diagnosed. Whether you lean on the cautious estimate of ~9.5 million Americans or the more realistic ~21.5 million, the message is the same: ME/CFS is a condition that rivals the scale of diabete
Aug 24


Comprehensive ME/CFS Overview – Correcting Undercounts and the Global Public Health Crisis
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating, multi-system neuroimmune disease on par with multiple sclerosis or congestive heart failure in severity, but for decades, it’s been sidelined by global health systems. Underdiagnosis, outdated clinical criteria, systemic bias, and institutional inertia have obscured its true scale. The result: tens of millions worldwide excluded from diagnosis, care, or recognition.
Aug 24


Modern Science Is Gaslighting You: Go From Anecdote to Evidence
They called your symptoms anecdotal. They called your story rare. But inside your medical records, flare journals, and sleepless nights is the dataset no one bothered to decode. This isn’t just a blog post, it’s a call to reclaim your role as more than a subject. Inside, we share how a self-paced case study course helps patients and caregivers turn lived experience into lasting change.
Aug 23
bottom of page
